Kerim Şeker

Dr. Kerim Şeker

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
OUOzge ULAS
Ozge ULAS
ZHZekiye Hasbek
Zekiye Hasbek
KŞKerim Şeker
Kerim Şeker
Introduction: This study aimed to evaluate the relationship between pathological and clinical risk classifications in newly diagnosed prostate cancer patients, and 68Ga-PSMA PET/CT data and serum Prostate Specific Antigen (PSA) values. Method: A total of 203 patients who were diagnosed with prostate cancer between 2019 and 2023, who had not yet received treatment and who underwent 68Ga-PSMA PET/CT for staging purposes were included in this study. Results: There was a substantial correlation between D’Amico risk classification, Gleason score, ISUP classification, and the presence or absence of metastasis (p < 0.0001). The median SUVmax value of the prostate gland and the D’Amico risk classification were statistically significantly correlated. (p < 0.0001). There was a statistically significant correlation between the ISUP classification and the PSA value and prostate gland SUVmax value (p < 0.0001). There was a significant correlation between the median SUVmax values of the prostate gland at the time of diagnosis and the patients with and without metastases (p < 0.0001). According to the data obtained from ROC analysis, patients with prostate gland SUVmax values of 8.75 and above were found to have a high probability of metastasis with a sensitivity of 78.9% and a specificity of 59.05%. Conclusion: Our study showed that 68Ga-PSMA PET/CT is a highly effective method for staging newly diagnosed high-risk prostate cancer. The probability of metastasis was found to be dramatically increased in Gleason 8 and above. According to D’Amico risk classification, metastasis was detected in at least half of high-risk patients. Since the sensitivity of metastasis was 78.9% in patients with prostate gland SUVmax value above 8.75, we think that these patients should be carefully reported in terms of metastasis.

6 January 2026 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
KŞKerim Şeker
Kerim Şeker
UAUğuray Aydos
Uğuray Aydos
MUMurat Uçar
Murat Uçar
ÜAÜ. Özgür Akdemir
Ü. Özgür Akdemir
LAL. Özlem Atay
L. Özlem Atay
Purpose: To evaluate the relationships between anatomical, functional, and metabolic parameters and distant metastasis in the primary staging of rectal adenocarcinoma. Methods: Seventy-three patients with rectal adenocarcinoma, who underwent pelvic MRI and whole-body 18 F-FDG PET/MRI for staging, were included. Anatomical [T and N stages, extramural venous invasion (EMVI) and circumferential resection margin (CRM) statuses] and functional parameters [apparent diffusion coefficient (ADC) mean (mm²/sn × 10 −6 )] of primary tumor were recorded from pelvic MRI, and metabolic data (maximum standard uptake value (SUV max ), mean SUV (SUV mean ), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and total lesion quotient (TLQ) were recorded from 18 F-FDG PET/MRI. Quantitative parameters combining functional and metabolic data (SUV max /ADC mean , SUV mean /ADC mean , MTV/ADC mean , TLG/ADC mean , TLQ/ADCmean) were calculated. Distant metastases were recorded via 18 F-FDG PET/MRI. To detect lung nodules, supplementary 18 F-FDG PET/CT scans of the thorax were utilized. Relationship between these parameters and distant metastasis, and their ability to predict for distant metastatic disease, were statistically evaluated. Results: In the univariate logistic regression analysis, the SUV max (1.04; 1.0–1.08; P = 0.031), TLG (1.0; 1.0–1.005; P = 0.044), TLG/ADC mean (8.12; 1.04–63.78; P = 0.046), and presence of EMVI (4.13; 1.31–12.98; P = 0.015) (OR; CI; P ) were found to predict distant metastasis. In multivariate regression analysis, SUV max (1.05; 1.0–1.1; P = 0.023) and the presence of EMVI (6.82; 1.64–28.48; P = 0.008) were identified as independent predictors for distant metastatic disease (OR; CI; P ). Significant associations were detected between distant lymph node metastasis and T stage and the presence of EMVI, whereas significant associations were detected between the size of distant lymph node metastases and the SUV max , SUV mean , SUV max /ADC mean , and SUV mean /ADC mean ( P < 0.05). Patients with lung and other organ metastases had significantly greater TLG and TLG/ADC mean values ( P < 0.05). Conclusion: 18 F-FDG PET/MRI allows obtaining anatomical, functional, and metabolic parameters related to the primary tumor in a single session and has the potential to predict information regarding tumor behavior, including distant metastatic spread.

23 June 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
ÜAÜmit Özgür Akdemir
Ümit Özgür Akdemir
IYİrEm Yildirim
İrEm Yildirim
SASeda Gülbahar Ateş
Seda Gülbahar Ateş
KŞKerim Şeker
Kerim Şeker
UAUğuray Aydos
Uğuray Aydos
EBErhan Bi̇lİr
Erhan Bi̇lİr
Background/aim: In temporal lobe epilepsy (TLE), brain positron emission tomography (PET) performed with F-18 fluorodeoxyglucose (FDG) is commonly used for lateralization of the epileptogenic temporal lobe. In this study, we aimed to evaluate the success of quantitative analysis of brain FDG PET images using data mining methods in the lateralization of the epileptogenic temporal lobe. Materials and methods: Presurgical interictal brain FDG PET images of 49 adult mesial TLE patients with a minimum of 2 years of postsurgical follow-up and Engel I outcomes were retrospectively analyzed. Asymmetry indices were calculated from PET images from the mesial temporal lobe and its contiguous structures. The 148 and the logistic model tree (LMT) data mining algorithms were used to find classification rules for the lateralization of the epileptogenic temporal lobe. The classification results obtained by these rules were compared with the physicians' visual readings and the findings of single-patient statistical parametric mapping (SPM) analyses in a test set of 18 patients. An additional 5-fold cross-validation was applied to the data to overcome the limitation of a relatively small sample size. Results: In the lateralization of 18 patients in the test set, J48 and LMT methods were successful in 16 (89%) and 17 (94%) patients, respectively. The visual consensus readings were correct in all patients and SPM results were correct in 16 patients. The 5-fold cross-validation method resulted in a mean correct lateralization ratio of 96% (47/49) for the LMT algorithm. This ratio was 88% (43 / 49) for the J48 algorithm. Conclusion: Lateralization of the epileptogenic temporal lobe with data mining methods using regional metabolic asymmetry values obtained from interictal brain FDG PET images in mesial TLE patients is highly accurate. The application of data mining can contribute to the reader in the process of visual evaluation of FDG PET images of the brain.

2 January 2026 in Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Verified
Journal Article
Closed access
KŞKerim Şeker
Kerim Şeker
OUOzge ULAS
Ozge ULAS
ZHZekiye Hasbek
Zekiye Hasbek

2 June 2026 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
KŞKerim Şeker
Kerim Şeker
EÇEmrah Çeltikçi
Emrah Çeltikçi
UAUğuray Aydos
Uğuray Aydos
MIMehmet Arda İnAn
Mehmet Arda İnAn
SASeda Gülbahar Ateş
Seda Gülbahar Ateş
LALütfiye Özlem Atay
Lütfiye Özlem Atay
Objectives: To evaluate the diagnostic utility of simultaneous fluorine-18 fluorodeoxyglucose ( 18 F-FDG) PET/MRI quantitative parameters in characterizing glioma heterogeneity and predicting isocitrate dehydrogenase (IDH) mutation status, based on the 2021 WHO Classification. Methods: Twenty-five patients with histopathologically confirmed gliomas underwent preoperative simultaneous 18 F-FDG PET/MRI. Forty-one biopsy foci were analyzed. Maximum standardized uptake value (SUV max ), normalized SUV (nSUV) ratios, minimum apparent diffusion coefficient, perfusion index, and cerebral blood flow (CBF), were measured. Patients were stratified into low-grade and high-grade groups (including molecular glioblastoma), according to the 2021 WHO criteria. Generalized estimating equations (GEE) were used alongside standard nonparametric tests to account for clustered biopsy data. Results: High-grade tumors exhibited significantly higher SUV and lower minimum apparent diffusion coefficient values compared to low-grade tumors ( P < 0.001). While perfusion parameters showed limited significance in standard unadjusted analyses, GEE analysis revealed them as highly significant predictors for high-grade status. IDH-wildtype (IDH-wt) tumors demonstrated significantly higher perfusion values ( P < 0.001) and tumor-to-white matter metabolic ratios (nSUV). Receiver operating characteristic analysis confirmed high diagnostic performance for SUV max [area under the curve (AUC) = 0.938] and CBF (AUC = 0.875) in discriminating tumor grade. Similarly, nSUV1 (AUC = 0.873) and CBF (AUC = 0.825) proved effective for predicting IDH-wt status. Conclusion: Simultaneous 18 F-FDG PET/MRI provides complementary metabolic and functional information for glioma characterization. When intratumoral heterogeneity is accounted for using GEE, perfusion parameters emerge as robust biomarkers for predicting high-grade histology and IDH-wt status. These findings support a multimodal approach to guide stereotactic biopsies to the most aggressive intratumoral foci.

16 June 2026 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
KŞKerim Şeker
Kerim Şeker
HGHüsnü Çağrı Genç
Hüsnü Çağrı Genç
TKTülay Koç
Tülay Koç
MYMukaddes Yılmaz
Mukaddes Yılmaz
ZHZekiye Hasbek
Zekiye Hasbek
Purpose: This study aims to assess the diagnostic performance of 18 F-FDG PET/CT parameters for the preoperative prediction of axillary lymph node (ALN) metastasis in Luminal A-type breast cancer patients, and to investigate the net clinical benefit of combining visual analysis with quantitative metrics. Materials and methods: We retrospectively evaluated 279 treatment-naive female patients histopathologically diagnosed with Luminal A type breast cancer who underwent 18 F-FDG PET/CT for staging and subsequent ALN sampling between January 2012 and December 2025. Both visual assessment and quantitative parameters—including maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumor, as well as axillary SUVmax and the axilla-to-primary SUVmax ratio (SUVr)—were analyzed by two nuclear medicine specialists in consensus. Diagnostic performance was measured using ROC analysis and DeLong’s test. The incremental value of the models was evaluated through Net Reclassification Improvement (NRI) and Integrated Discrimination Improvement (IDI), while clinical utility was determined via Decision Curve Analysis (DCA). Results: ALN metastasis was confirmed in 152 (54.5%) patients. All quantitative parameters were significantly higher in the metastatic group (p < 0.001). While expert-based visual analysis showed 84.6% accuracy, axillary SUVmax (AUC: 0.881, 95% CI: 0.841–0.920) significantly outperformed visual assessment (AUC: 0.851, p = 0.031). At a cutoff of 0.93, axillary SUVmax yielded 83.6% sensitivity and 79.5% specificity. The Combined Model, integrating visual and quantitative data, achieved the highest diagnostic power (AUC: 0.889) and was statistically superior to axillary SUVmax alone (p = 0.022). The incorporation of quantitative data correctly reclassified 29% (NRI) of metastatic patients initially reported as false negatives in visual analysis and improved overall discrimination by 41.4% (IDI). DCA revealed that the combined model offered a higher net clinical benefit than standard surgical approaches within a 20–90% risk threshold range. Conclusion: In Luminal A-type breast cancer, objective quantitative 18F-FDG PET/CT parameters and their derived multiparametric models significantly exceed the diagnostic limitations of conventional visual assessment. By providing high net clinical benefit in the surgical decision-making process, the proposed combined model has the potential to serve as a valuable personalized decision support tool for the management of high-risk patients and the de-escalation of invasive surgery in low-risk cohorts.